Scientists studied the potential of psychedelics, such as psilocybin mushrooms and LSD, in treating Obsessive-Compulsive Disorder (OCD). An online survey with 174 participants revealed over 30% experienced prolonged positive effects from these substances on their OCD symptoms. However, due to...
A new study in Substance Use & Misuse found a significant increase in LSD use among U.S. business managers from 2006 to 2014. Analyzing data from over 168,000 full-time workers, the research showed a 1100% rise in LSD use among...
Recent research has shown that psychedelic drugs, including psilocybin, LSD, and MDMA, have the potential to significantly reduce depression and anxiety symptoms in patients with advanced cancer. The effectiveness of these drugs may stem from their ability to help patients...
Researchers have uncovered surprising findings about the effects of two commonly known drugs, MDMA (commonly referred to as ecstasy) and methamphetamine, on human connection and feelings of closeness with conversation partners. Contrary to expectations, both drugs were found to enhance...
A recent study sheds light on how mental health professionals perceive an emerging form of treatment known as psychedelic-assisted therapy (PAT). The findings reveal intriguing variations in the attitudes and beliefs of psychologists, clinical social workers, and psychiatrists about this...
In recent years, the trend of microdosing psychedelics has gained popularity, with enthusiasts touting a wide range of potential benefits, from enhanced creativity to improved mood and focus. However, a recent scientific review published in the Journal of Psychopharmacology has...
A recent multi-site study published in the Journal of the American Medical Association revealed that psilocybin-assisted therapy offers rapid and sustained antidepressant effects for individuals with major depressive disorder. Compared to an active placebo, the treatment improved psychosocial functioning and...
A recent scientific study has uncovered an intriguing connection between the use of psilocybin, the psychoactive compound found in certain "magic" mushrooms, and reduced overtime work among full-time employees. While the study's findings aren't conclusive proof of causation, they shed...
In a phase II clinical trial, a single dose of psilocybin, combined with SSRI treatment and supportive therapy, showed promising safety and therapeutic outcomes for individuals with treatment-resistant depression. While the results suggest that SSRIs do not inhibit the potential...
A recent study published in the Journal of Psychoactive Drugs analyzed DMT (dimethyltryptamine) experiences shared on Reddit to understand the profound sense of familiarity reported by users. The research found that the sense of familiarity was a distinct aspect of...
A recent study published in the Journal of Psychopharmacology suggests that psilocybin, the active component in "magic mushrooms", can induce lasting neuroplastic changes in the brain, which are associated with improvements in symptoms of depression. The research, which found significant...
An online survey published in the International Journal of Mental Health and Addiction found that after beginning psychedelic use, many adults reduced or stopped their intake of alcohol, antidepressants, and cocaine, but increased their consumption of cannabis and tobacco. The...
A recent study in ACS Pharmacology & Translational Science discovered that a temporary spike in stress hormones, specifically corticosterone, plays a central role in reducing anxiety-like behaviors in mice given the psychedelic substance psilocybin. The findings offer crucial insights into...
New research published in the journal Communication Biology shows that psychedelic substances like LSD and ketamine induce "hypersynchrony" in the brain, characterized by highly synchronized high-frequency oscillations across different regions. This unique synchronization, observed in rats, provides insights into altered...
A recent case study published in Frontiers in Psychology compared the experiences of a near-death experience (NDE) and an experience induced by the psychedelic drug 5-MeO-DMT in a 54-year-old man. While the study found notable similarities such as ego dissolution...